| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 75.478 | 88.452 | 85.432 | 151.980 | 187.835 | 151.632 | 165.602 | 144.064 | 116.638 | 109.714 |
| Total Income - EUR | 75.478 | 88.452 | 85.432 | 152.227 | 187.835 | 161.976 | 165.602 | 144.064 | 116.638 | 113.735 |
| Total Expenses - EUR | 18.093 | 19.059 | 20.350 | 25.081 | 25.904 | 21.951 | 20.551 | 27.994 | 31.152 | 37.300 |
| Gross Profit/Loss - EUR | 57.385 | 69.393 | 65.081 | 127.146 | 161.930 | 140.025 | 145.051 | 116.069 | 85.486 | 76.435 |
| Net Profit/Loss - EUR | 55.121 | 68.508 | 64.227 | 125.624 | 160.052 | 138.405 | 143.410 | 114.628 | 84.320 | 73.143 |
| Employees | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Cadomedica 93 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.581 | 636 |
| Current Assets | 113.697 | 181.342 | 239.809 | 358.327 | 508.439 | 205.793 | 216.515 | 116.203 | 85.766 | 74.834 |
| Inventories | 482 | 498 | 383 | 249 | 244 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 35 | 0 | 0 | 21 | 20 | 1.970 | 3.719 | 89.379 | 52.817 | 58.517 |
| Cash | 113.179 | 180.844 | 239.427 | 358.057 | 508.174 | 203.822 | 212.797 | 26.824 | 32.949 | 16.317 |
| Shareholders Funds | 55.245 | 68.631 | 64.348 | 125.742 | 160.168 | 138.519 | 143.521 | 114.740 | 84.431 | 73.254 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 58.452 | 112.711 | 175.462 | 232.585 | 348.271 | 67.273 | 72.994 | 1.463 | 5.916 | 2.216 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cadomedica 93 Srl